Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Malignant Primary Pelvic Neoplasm 1

Interventions

Paclitaxel 36Bevacizumab 31Carboplatin 29pembrolizumab 25Specimen Handling 20Magnetic Resonance Spectroscopy 18olaparib 16Cisplatin 15liposomal doxorubicin 13Gemcitabine 13Taxes 12Immunoglobulin G 11Disulfides 11Topotecan 10Nivolumab 9Cyclophosphamide 9Doxorubicin 8Biopsy 8fludarabine 7mirvetuximab soravtansine 6niraparib 5Radiation 5Oxaliplatin 5Fulvestrant 5Fluorouracil 5trastuzumab deruxtecan 4durvalumab 4cediranib 4Platinum 4Megestrol Acetate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Exercise Test × Gynecologic × 30 days × Clear all
NCT05134142 2026-05-20

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

M.D. Anderson Cancer Center

Recruiting
200 enrolled
Gynecologic

Malignant Primary Pelvic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡